Effects Of Inhaled Aviptadil (Vasoactive Intestinal Peptide) In Patients With Pulmonary Arterial Hypertension (PAH)

Authors :: Robert Naeije
Andrew J. Peacock
Ralf Ewert
Anco Boonstra
H Bremer
Hanno Leuchte
Hans Klose
Miguel Ángel Gómez-Sánchez
Dorian Bevec
Adam Torbicki
Joan Albert Barberà
Heinrike Wilkens
Gérald Simonneau
Lewis J. Rubin
Nazzareno Galiè
Ardeschir Ghofrani
Gerald Bacher
Ekkehard Gruenig
Vera Cavalli
Source :: B16. PULMONARY ARTERIAL HYPERTENSION: FROM ASSESSING RISK TO THERAPEUTIC RESULTS.
Publication Year :: 2010
Publisher :: American Thoracic Society, 2010.

Subjects :: medicine.medical_specialty
business.industry
Internal medicine
Vasoactive intestinal peptide
medicine
In patient
business
Gastroenterology
Aviptadil
medicine.drug

Database :: OpenAIRE
Journal :: B16. PULMONARY ARTERIAL HYPERTENSION: FROM ASSESSING RISK TO THERAPEUTIC RESULTS
Accession number :: edsair.doi...........2d416618ca58fe10592fd361a81384c8
Full Text :: https://doi.org/10.1164/ajrccm-conference.2010.181.1_meetingabstracts.a2516

Full Text Access

Tools